Spreading depression: from serendipity to targeted therapy in migraine prophylaxis.
about
Pharmacological targeting of spreading depression in migraineSpreading Depression, Spreading Depolarizations, and the Cerebral VasculatureInsights into migraine mechanisms and CaV2.1 calcium channel function from mouse models of familial hemiplegic migraine.Targeting TRP channels for novel migraine therapeutics.Synthesis and in vitro biological evaluation of carbonyl group-containing analogues for σ1 receptors.Comparison of Levetiracetam and sodium Valproate in migraine prophylaxis: A randomized placebo-controlled study.Critical role of calcitonin gene-related peptide receptors in cortical spreading depression.Presynaptic CaV2.1 calcium channels carrying familial hemiplegic migraine mutation R192Q allow faster recovery from synaptic depression in mouse calyx of Held.Glucose modulation of spreading depression susceptibilityCortical spreading depression as a target for anti-migraine agents.Vagus nerve stimulation inhibits cortical spreading depressionNitroglycerin enhances the propagation of cortical spreading depression: comparative studies with sumatriptan and novel kynurenic acid analoguesAnimal models of headache: from bedside to bench and back to bedside.Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury.Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies.The role of the visual system in migraine: an update.Endogenous mechanisms underlying the activation and sensitization of meningeal nociceptors: the role of immuno-vascular interactions and cortical spreading depression.The pathophysiological and pharmacological basis of current drug treatment of migraine headache.Pearls and pitfalls in experimental models of spreading depression.Closing remarks: what future prospects can we expect in migraine management?Temporal fate specification and neural progenitor competence during development.Spreading Depolarizations: A Therapeutic Target Against Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.Suppressive effect of chronic peroral topiramate on potassium-induced cortical spreading depression in rats.Advances in drug development for acute migraine.Protection of flunarizine on cerebral mitochondria injury induced by cortical spreading depression under hypoxic conditions.Oxcarbazepine does not suppress cortical spreading depression.Poloxamer-188 and citicoline provide neuronal membrane integrity and protect membrane stability in cortical spreading depression.Active role of capillary pericytes during stimulation-induced activity and spreading depolarization
P2860
Q27004042-44D524F7-5DED-4475-B18D-DAB2350A6038Q28264417-E2875D03-79A7-4FE3-A0B7-851B3BA255CEQ33535616-9D2D1376-AC9E-4D99-BB98-01B695156870Q34555756-A6968F0B-FDB9-4B7B-B1C6-12B3FB8FAFF5Q35148443-8EE347E7-46D4-4319-91A4-B1C8D12373CDQ35149187-FCD6EADA-6B97-4200-A61F-04572DA75023Q36414887-0CB6567F-7473-45FC-9796-33000DA34A25Q36531989-8BEBDF1E-3DD1-470F-88AE-D35147CD6157Q36587054-3C9BC201-7E12-4672-A6DF-71207BDB2E4CQ37056769-EBFFF099-5AE2-4E39-A6A8-17FA2C55B8B6Q37091705-176F04AD-AC3F-441F-BFDC-908C6F08825BQ37538111-2F1F9BAB-7692-4733-8D33-D341CBA4A34AQ37699421-E483C0B9-A9D9-49A1-8E68-CE3FB073A775Q37806624-C1660770-59B6-4831-9425-6E2FA7D0D243Q37858847-CF5391C8-6105-4149-A1F8-876F4AE158E0Q37870789-80398D48-75AF-4300-913B-7067D3A39062Q37983508-68F2091F-F77D-4B33-AB79-EA7DB851634CQ38105147-9D60723B-B0A2-47EB-BD44-B2DC665CF758Q38106686-401695EA-BF54-44B4-82EA-6218F8068F8EQ38108476-9FDF52FE-71CC-4152-8FD1-056976313FEAQ38176634-872A52D9-4EF8-42DF-A28D-CDE119315334Q38852763-939050E3-081D-4FBC-A679-6C9C6BAA9920Q39248893-15625348-3072-4BB8-823E-888A3210CC65Q39527265-1E2A8CC6-B2DE-44EB-8935-F0015EE52071Q42682905-A8A50457-5F0D-4C4D-82D3-5F6EACDB9DC5Q44769570-9E5E97AF-F86F-431D-B105-CC2F9B87427AQ48187119-B2A54272-C866-4942-BBF9-3879CDB80952Q58049057-F72F05F0-CC76-4AA6-A78B-ACC1F6B2ABAF
P2860
Spreading depression: from serendipity to targeted therapy in migraine prophylaxis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Spreading depression: from serendipity to targeted therapy in migraine prophylaxis.
@en
Spreading depression: from serendipity to targeted therapy in migraine prophylaxis.
@nl
type
label
Spreading depression: from serendipity to targeted therapy in migraine prophylaxis.
@en
Spreading depression: from serendipity to targeted therapy in migraine prophylaxis.
@nl
prefLabel
Spreading depression: from serendipity to targeted therapy in migraine prophylaxis.
@en
Spreading depression: from serendipity to targeted therapy in migraine prophylaxis.
@nl
P2860
P1433
P1476
Spreading depression: from serendipity to targeted therapy in migraine prophylaxis.
@en
P2093
P2860
P304
P356
10.1111/J.1468-2982.2009.01982.X
P407
P577
2009-10-01T00:00:00Z